Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease

American Heart Journal

Volumn 160, Issue 2, 2010, Pages

  Anderson, Jeffrey L ^a,b   Horne, Benjamin D ^a,b   Camp, Nicola J ^b   Muhlestein, Joseph B ^a,b   Hopkins, Paul N ^b   Cannon Albright, Lisa A ^b   Mower, Chrissa P ^a   Park, James J ^a   Clarke, Jessica L ^a   Nicholas, Zachary P ^a   McKinney, Jason T ^c   Carlquist, John F ^a,b  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Idaho Technology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN F; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

ADULT; ANGIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILIAL INCIDENCE; FAMILY HISTORY; FEMALE; GENE LOCUS; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; HYPERTENSION; MALE; MULTIGENE FAMILY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 77955438574     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.031     Document Type: Article

References (45)

1. Hopkins P.N., Hunt S.C., and Wu L.L. Family history and genetic factors N.D. Wong, H.R. Black, J.M. Gardin, Preventive cardiology, a practical approach 2005 McGraw-Hill New York 92 148
2. Anderson J.L., Carlquist J.F., and Horne B.D. Progress in unraveling the genetics of coronary artery disease and myocardial infarction Current Atherosclerosis Reports 9 2007 179 186
3. Hirschhorn J.N. Genomewide association studies-illuminating biologic pathways N Engl J Med 360 2009 1699 1701
4. Topol E.J., Smith J., and Plow E.F. Genetic susceptibility to myocardial infarction and coronary artery disease Hum Molec Genet 15 2006 R117 R123
5. Horne B.D., Anderson J.L., and Carlquist J.F. Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints Ann Human Genetics 69 2005 176 186
6. Piccolo S.R., Abo R.P., and Allen-Brady B.K. Evaluation of genetic risk scores for lipid levels using genome wide markers in the Framingham Heart Study BMC 3 Suppl 7 2009 546
7. Kathiresan S., Melander O., and Anevski D. Polymorphisms associated with cholesterol and risk of cardiovascular events N Engl J Med 358 2008 1240 1249
8. Taylor G.S., Muhlestein J.B., and Wagner G.S. Implementation of a computerized cardiovascular information system in a private hospital setting Am Heart J 136 1998 792 803
9. Horne B.D., Camp N.J., and Carlquist J.F. Multiple-polymorphism associations of seven matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease Am Heart J 154 2007 751 758
10. Horne B.D., Carlquist J.F., and Muhlestein J.B. Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease Circulation Cardiovascular Genetics 1 2008 85 92
11. Horne B.D., Carlquist J.F., and Cannon-Albright L.A. High-resolution characterization of linkage disequilibrium structure and selection of tagging SNPs for the cholesteryl ester transfer protein gene Ann Human Genetics 70 2006 524 534
12. Horne B.D., Camp N.J., and Anderson J.L. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease J Am Coll Cardiol 49 2007 2053 2060
13. Cornelis M.C., Qi L., and Zhang C. Joint effects of common genetic variants on the risk of type 2 diabetes in U.S. men and women of European ancestry Ann Intern Med 150 2009 541 550
14. Horne B.D., Camp N.J., and Carlquist J.F. Modeling multiplicative SNP interactions in the presence of an additive genetic risk score Genet Epidemiol 33 2009 771
15. Balding D.J. A tutorial on statistical methods for population association studies Nat Rev Genet 7 2006 781 791
16. Pencina J.J., D'Agostino R.B.S., and D'Agostino R.B.J. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Statist Med 27 2008 157 172
17. Hlatky M.A., Greenland P., and Arnett D.K. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416
18. Ridker P.M., Buring J.E., and Rifai N. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women JAMA 297 2007 611 619
19. Cook N.R. Use and misuse of receiver operating characteristic curves in risk prediction Circulation 115 2007 928 935
20. Cook N.R., and Ridker P.M. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures Ann Intern Med 150 2009 795 802
21. Goldstein D.B. Common genetic variation and human traits N Engl J Med 360 2009 1696 1698
22. Kraft P., and Hunter D.J. Genetic risk prediction-are we there yet? N Engl J Med 360 2009 1701 1703
23. Lander E.S. The new genomics: global views of biology Science 274 1996 536 539
24. Anderson J.L., Horne B.D., and Kolek M.J. Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility Am Heart J 156 2008 1155 1162
25. Dandona S., Stewart A.F.R., and Chen L. Gene dosage of the common variant 9p21 predicts severity of coronary artery disesae J Am Coll Cardiol 56 2010 [in press]
26. Talmud P.J., Cooper J.A., and Palmen J. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men Clin Chem 54 2008 467 474
27. Brautbar A., Ballantyne C.M., and Lawson K. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifiying therapy in Atherosclerosis Risk in Communities study Clin Cardiovasc Genet 2 2009 279 285
28. Paynter N.P., Chasman D.I., and Buring J.E. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3 Ann Intern Med 150 2009 65 72
29. Coronary Artery Disease Consortium Large scale association analysis of novel genetic loci for coronary artery disease Arterioscl Thromb Vasc Biol 29 2009 775 780
30. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
31. Horne B.D., and Camp N.J. Principal component analysis for selection of optimal SNP-sets that capture intragenic genetic variation Genet Epidemiol 26 2004 11 21
32. McPherson R., Pertsemlidis A., and Kavaslav N. A common allele on chromosome 9 associated with coronary heart disease Science 316 2007 1488 1491
33. Helgadottir A., Thorleifsson G., and Manolescu A. A common variant on chromosome 9p21 affects the risk of myocardial infarction Science 316 2007 91 93
34. Wellcome Trust Case-Control Consortium Genome-wide association study of 14,000 cases of seven common disease and 3,000 shared controls Nature 447 2007 661 678
35. Samani N.J., Erdmann J., and Hall A.S. Genomewide association analysis of coronary artery disease N Engl J Med 357 2007 443 453 (Pubitemid 47204873)
36. Schunkert J., Goetz A., and Braund P. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease Circulation 117 2008 1675 1684
37. Anderson J.L., Horne B.D., and Kolek M.J. Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility Am Heart J 156 2008 1155 1162
38. Saxena R., Voight B.F., and Lyssenko V. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 2007 1331 1336
39. Benjamin E.J., Dupuis J., and Larson M.G. Genome-wise association with select biomarker traits in Framingham Heart Study BMC Medical Genetics 8 2007 1 12
40. Zheng Y., Liu E.H.C., and Higg J.P.T. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls Lancet 367 2006 651 658
41. Kathiresan S., Melander O., and Anevski D. Polymorphisms associated with cholesterol and risk of cardiovascular events N Engl J Med 358 2008 1240 1249
42. Kathiresan S., Melander O., and Guiducci C. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, or triglycerides in humans Nat Genet 40 2008 189 197
43. Cohen J.C., Boerwinkle E., Mosley T.H., and Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease N Engl J Med 354 2006 1264 1272
44. Willer C.J., Sanna S., and Jackson A.U. Newly identified loci that influence lipid concentrations and risk of coronary artery disease Nat Genet 40 2008 161 169
45. Ridker P.M., Buring J.E., Rifai N., and Cook N. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women JAMA 297 2007 611 619